CME: Overcoming barriers to the prevention and management of antimicrobial-resistant bacterial infections: updates from ID Week 2021
ACCREDITATION EXPIRED: January 21, 2023
Activity Description / Statement of Need:
In this online, self-learning activity:
Antimicrobial resistance (AMR) is a phenomenon fueled by the selection pressure leveled against microorganisms through the use and misuse of antibiotics in clinical and agricultural settings as well as horizontal gene transfer between pathogens. Far from the prediction in the 1960s that most problems associated with infectious disease had been addressed by the close of World War II, Sir Alexander Fleming’s 1945 prediction that public demand for antibiotics would usher in an era of overuse has proved far more prophetic. The World Health Organization (WHO) predicts that by 2050, there could be up to 10 million deaths caused by drug-resistant infections each year, and treatment of multidrug infections is estimated to cost the US $4.6 billion per year. Once derided as a figment of apocalyptic fearmongering, the specter of a post-antibiotic era has begun to loom too close for comfort. [
This learning activity has been designed to improve HCPs’ knowledge of effective anti-infective use in the context of antimicrobial stewardship and novel antibiotics as well as improve their competency and performance in applying that knowledge to practice.
Target Audience:
HCPs specializing in: infectious disease, critical care, and primary care; physician assistants, nurse practitioners, and pharmacists who practice in the aforementioned areas of specialty; and any other healthcare professionals with an interest in or who treat patients with antimicrobials.
Commercial Support Disclosure: This program is supported by an educational grant from Merck.
This activity is free of charge.
Release Date: January 21, 2022 -- Expiration Date: January 21, 2023
Faculty: Lucy Horton, MD, MPH
Agenda
|
Overview of AMR |
|
Major findings from ID Week 2021, including clinical trial data relevant to both community and health-system practice and recognized barriers to implementing those findings in practice |
Learning Objectives
By the end of the session the participant will be able to:
- Summarize the most impactful findings presented at ID Week 2021 meeting relating to AMR, and apply them to patient cases.
- Discuss novel antimicrobial therapeutic options and their role in treating serious Gram negative infections
- Describe the impact of the COVID-19 pandemic on AMR and antibiotic stewardship
Accreditation
ACCME Activity #201820639
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
Faculty Disclosure and Resolution of COI
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Faculty Disclosure: Lucy Horton, M.D., MPH has no relevant financial disclosures.
Faculty DOES NOT plan on discussing off-label uses of a commercial product.
Disclosures of Educational Planners: Charles Turck, PharmD, BCPS, BCCCP, President of ScientiaCME, has no relevant financial disclosures.
Commercial Support Disclosure: This program is supported by an educational grant from Merck.
All relevant financial relationships have been mitigated.
ScientiaCME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Faculty DOES plan on discussing off-label uses of a commercial product.
Instructions
- Read the learning objectives above
- Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
- View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
- Minimum participation threshold: Take the post-test. A score of 70% or higher is required to pass and proceed to the activity evaluation.
- Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.
System Requirements
Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.